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The mean age at onset is 31.7±27.0 years (mean±SD) [3] . Clinical features are variable, with the three most frequently observed categories being psychiatric signs (70-80% of cases), movement disorders (40-77% of cases), and cognitive impairment (40-65% of cases) [4] . CT-scan and MRI showed large calcifications in the basal ganglia and cerebellar dentate nuclei ( Figure 1B ). Interestingly, also his sister, who denied the CT-scan, exhibited basal ganglia calcifications at transcranial sonography.
Case 3 was a 41-year-old Albanian female who presented with a long history of migraines without aura of moderate-to-severe intensity, and characterized by pulsating pain, accompanied by nausea, and photo/phonophobia, lasting up to 24 hours. Neurological examination was normal as well as laboratory investigations. A CT-scan at 37 yrs. showed calcifications at the bilateral putamen and small deposits at the bilateral globus pallidus and dentate nuclei ( Figure 1C ).
Interestingly, 4 years later, the CT-scan showed an increase of ~30% in calcification volume ( Figure 1D ).
Sanger sequencing of SLC20A2 (NM_006749) identified three novel missense variants: i) case 1, c.188G>A in exon 2 (p.Gly63Asp; Figure 1E) ; ii) case 2, c.187G>A in exon 2 (p.Gly63Ser; Figure 1F ). Notably, the mutation segregates in the patient's sister affected by BD type 2 and cognitive impairment; iii) case 3, c.1196A>C in exon 8 (p.His399Pro; Figure 1G ).
All three changes were not reported in genetic databases (ExAc, dbSNPs, HapMap, 1000 Genomes, Exome Variant Server); the mutations affected highly conserved amino acids ( Figure 1H ), and were predicted as pathogenic by bioinformatics (Supplemental Table 1 ). Based on ACMG recommendations, the three variants are classified as "class 4-likely pathogenic". 5 Our study further support a lack of genotype/phenotype correlation for SLC20A2 mutations [4] . In two cases, glycine 63 was affected; the proband with p.Gly63Asp had migraines at onset, whereas the p.Gly63Ser substitution (case 2 and his sister) was associated with BD type 2, followed by cognitive impairment involving frontal functions (dysexecutive syndrome and visuospatial deficits). BD has been described in few PFBC patients [1, 5, 6] . However, only two cases of BD are reported in patients carrying SLC20A2 mutations: one with BD type 1 and motor tics, and one unspecified BD [1, 6] . To our knowledge, case 2 represents the first SLC20A2-mutated patient presenting with BD type 2.
Notably, MRI showed globus pallidus alteration also in case 2 with BD. This finding correlates with recent observations in BD, suggesting an involvement of this nucleus in maniac episodes [7] .
The relationship between basal ganglia calcifications (BGC) and neuropsychiatric symptoms is controversial. The basal ganglia are interconnected with frontal areas in parallel cortico-striatothalamo-cortical circuits, organized in five distinct functional loops. Three circuits play a major role in executive functions (prefrontal loop), regulation of social behavior and mood (orbito-frontal loop) and motivation (anterior cingulate circuit). Disruption of these fronto-subcortical loops has been proposed to occur in BGC [8] .
Cases 1 and 3 further support migraines without aura as the sole initial presentation of SLC20A2-related IBGC [1, 9] ; as this clinical feature is frequent in the general population, it is possible that it can co-occur with IBGC by chance.
Finally, we demonstrated a progression of the calcifications at the basal ganglia within just 4 years of the disease (case 3), suggesting that, following an initial trigger, the growth of the calcifications progresses rapidly. This observation could lead to a read-out for potential therapies, including the recently suggested vitamin D administration, which should reduce brain calcifications by upregulating SLC20A2 gene expression [10] . Regarding this, we found hypovitaminosis D in case 1, which may have modified the clinical progression. 6 In conclusion, we added BD type 2 as a novel psychiatric phenotype associated with SLC20A2 mutations, suggesting that BD patients, as well as those with adult onset migraines, should be investigated for the presence of basal ganglia calcifications.
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Figure 1. CT-scans and genetic findings.
A) and B) Severe calcifications in the bilateral globus pallidus, caudate nuclei, thalamus and dentate nuclei were present in the CT-scans of cases 1 (48 yrs.) and 2 (68 yrs.). C) Bilateral small calcifications in the putamen, globus pallidus and dentate nucleus in case 3 (37 yrs. 
